คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย เป็นหน่วยงานระดับคณะวิชาของจุฬาลงกรณ์มหาวิทยาลัย มีพระราชกฤษฎีกาประกาศตั้งเมื่อวันที่ 22 พฤษภาคม พ.ศ. 2490 มีผลบังคับใช้ในวันที่ 4 มิถุนายน พ.ศ. 2490 โดยสังกัดอยู่ภายใต้มหาวิทยาลัยแพทยศาสตร์ จนกระทั่งถูกโอนมาสังกัดจุฬาลงกรณ์มหาวิทยาลัยในปี พ.ศ. 2510

During the past decade, Faculty of Medicine Chulalongkorn University conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Faculty of Medicine Chulalongkorn University" #1 sponsor was "Chulalongkorn University" with 25 trials, followed by "The HIV Netherlands Australia Thailand Research Collaboration" with 2 trials sponsored, "King Chulalongkorn Memorial Hospital" with 1 trials sponsored, "Mahidol University" with 1 trials sponsored and "Reckitt Benckiser Healthcare (UK) Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Faculty of Medicine Chulalongkorn University" #1 collaborator was "Mahidol University" with 3 trials as a collaborator, "Chulalongkorn University" with 2 trials as a collaborator, "Chiang Mai University" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Nanotechnology Center (NANOTEC), The National Science and Technology Development Agency (NSTDA)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Faculty of Medicine Chulalongkorn University" are "Preterm Labor" (3 trials), "Acne Vulgaris" (1 trials), "Acute Generalized Exanthematous Pustulosis" (1 trials), "Allergic Rhinitis" (1 trials) and "Aspirin Allergy" (1 trials). Many other conditions were trialed in "Faculty of Medicine Chulalongkorn University" in a lesser frequency.

Most popular intervention types in "Faculty of Medicine Chulalongkorn University" are "Drug" (11 trials), "Procedure" (4 trials), "Device" (3 trials), "Diagnostic Test" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dydrogesterone" (2 trials), "placebo" (2 trials), "2940 nm Er:YAG laser (DualisXS M002-2A, Fotona®, Fotona d.d, Ljubljana, Slovenia)" (1 trials) and "Acetate-free dialysis solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Faculty of Medicine Chulalongkorn University" are 24 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Faculty of Medicine Chulalongkorn University". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Faculty of Medicine Chulalongkorn University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Faculty of Medicine Chulalongkorn University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 13 trials that are defined as “Not Applicable".